Alzheimer's Pathology, circa 1906

Alzheimer's drawing of a histological section from his second patient, Johann F. Credit: Image supplied by author, obtained from Zeitschrift fur die Gesamte Neurologie und Pyschiatrie, 1911." />Alzheimer's drawing of a histological section from his second patient, Johann F. Credit: Image supplied by author, obtained from Zeitschrift fur die Gesamte Neurologie und Pyschiatrie, 1911. On

Written byRalf Dahm
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

On November 26th 1901, Alois Alzheimer, an assistant physician at the psychiatric institution in Frankfurt, met his now-famous patient, Auguste D., for the first time. Soon into their first conversation, he realized that the 51 year old woman showed symptoms unlike any he had seen before. When Alzheimer asked her questions, her replies didn't match. She also often stopped mid-sentence, as if she had forgotten what she was going to say. She was confused and anxious. Alzheimer was intrigued, but it wasn't until nearly five years later that he got a first glimpse into the underlying pathology.

When Auguste D. died on April 8th 1906, Alzheimer, then head of the anatomy laboratory at the Royal Psychiatric Clinic in Munich, received her brain for histological analysis, and made drawings of what he saw. Right away, he realized that this case also differed anatomically from all known brain pathologies. Throughout the brain, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies